For Private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES’ RATING SYSTEM AND OTHER DISCLOSURES. REFER TO THE END OF THIS MATERIAL. Contents Special Reports Strategy Strategy: Opening economies, closing opportunities, Part 2 Economic conditions will improve from bottom levels; question is how much Stock prices in several sectors back to February 2020 levels; even higher in a few sectors FY2022E revenue, volume and PAT numbers down from pre-Covid-19 levels A rather skewed market; limited insights from top-down valuations Daily Alerts Results Hero Motocorp: One-offs impact operating performance 4QFY20 EBITDA margin dented by a few one-offs Cost-saving program and RM tailwinds to support operating margins in FY2021E Dhanuka Agritech: Robust results 4QFY20 results boosted by strong growth in revenues and higher margins Raise FY2021-22 EPS estimates; retain SELL with a revised fair value of Rs535 Results, Change in Reco TeamLease Services: Upgrade to ADD Temporary staffing: decent performance in a challenging environment HR services segment: remains under pressure Specialized staffing: should see decent momentum in FY2021 also Upgrade to ADD with a new FV of Rs1,875 INDIA DAILY June 11, 2020 India 10-Jun 1-day 1-mo 3-mo Sensex 34,247 0.9 8.5 (4.1) Nifty 10,116 0.7 9.5 (3.3) Global/Regional indices Dow Jones 26,990 (1.0) 11.4 14.6 Nasdaq Composite 10,020 0.7 9.0 26.0 FTSE 6,329 (0.1) 6.6 7.7 Nikkei 22,809 (1.4) 11.9 17.5 Hang Seng 25,050 (0.0) 1.8 (0.7) KOSPI 2,186 (0.4) 13.0 14.6 Value traded – India Cash (NSE+BSE) 558 606 558 Derivatives (NSE) 16,709 5,841 11,75 8 Deri. open interest 3,145 2,104 3,364 Forex/money market Change, basis points 10-Jun 1-day 1-mo 3-mo Rs/US$ 75.5 (11) (45) 131 10yr govt bond, % 6.3 (1) (9) (21) Net investment (US$ mn) 9-Jun MTD CYTD FIIs 63 2,800 (2,114) MFs (159) (365) 4,968 Top movers Change, % Best performers 10-Jun 1-day 1-mo 3-mo ARBP IN Equity 797 2.8 19.9 77.0 GNP IN Equity 401 (0.1) 19.8 55.1 CIPLA IN Equity 643 0.5 9.7 54.5 LPC IN Equity 928 1.0 9.3 45.3 CDH IN Equity 369 2.5 12.4 43.0 Worst performers MMFS IN Equity 154 (2.0) (2.2) (52.4) IIB IN Equity 500 7.7 15.3 (41.5) BAF IN Equity 2,436 (0.3) 20.9 (39.6) BJFIN IN Equity 5,223 (1.7) 14.6 (36.7) EDEL IN Equity 45 (0.7) 12.3 (33.8) [email protected]Contact: +91 22 6218 6427
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
For Private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES’ RATING SYSTEM AND OTHER DISCLOSURES. REFER TO THE END OF THIS MATERIAL.
Contents
Special Reports
Strategy
Strategy: Opening economies, closing opportunities, Part 2
Economic conditions will improve from bottom levels; question is how
much
Stock prices in several sectors back to February 2020 levels; even higher in a
few sectors
FY2022E revenue, volume and PAT numbers down from pre-Covid-19 levels
A rather skewed market; limited insights from top-down valuations
For Private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES’ RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.
Economic conditions will improve from bottom levels; question is how much
We make two (somewhat obvious) points about the economic recovery—(1) demand for most
goods and services will bounce back from depressed levels of April-May 2020, the period of
strict lockdown in India; there is limited reason to get excited about the same and (2) demand
for most goods and services in FY2022 will be likely lower than pre-Covid-19 estimates for
FY2022 even assuming a smooth recovery in the economy. We rule out a quick discovery of a
vaccine against Covid-19 and a large fiscal stimulus that can result in faster recovery in demand.
Stock prices in several sectors back to February 2020 levels; even higher in a few sectors
A simple analysis of pre-Covid-19 and current stock prices and FY2022E earnings/book (see
Exhibit 1) shows that stocks in consumer staples, pharmaceuticals and telecom (including RIL)
sectors are trading near or above their pre-Covid-19 prices while financials stocks are trading
significantly below their pre-Covid-19 levels. We would be the first to concede that 1-2 years of
lower earnings/cash flows are not very material for ‘fair’ values of stocks (unless business
models are impaired significantly) but the sharp rebound in stock prices in several sectors is
interesting. The market is rightly concerned about potential increase in NPLs and credit costs for
financials but seems less worried about weak demand conditions extending into FY2022 too.
FY2022E revenue, volume and PAT numbers down from pre-Covid-19 levels
We have cut our FY2022E volume/revenue assumptions and net profit estimates for most stocks
under our coverage given the risks to demand across sectors. Our aggregate net profits for the
Nifty-50 Index is down 20% from February 14, 2020 levels (roughly pre-Covid-19 period). In
particular, we have seen sharp cuts in the case of automobiles, banks and diversified financials,
commodities and modest cuts in the case of consumer staples sectors. Exhibit 2 compares the
pre-Covid-19 and current FY2022E volume, revenues, EBITDA, net profits and book value
estimates of the Nifty-50 stocks. We ignore FY2021E numbers for most sectors given significant
disruption to both demand and supply in 1QFY21.
A rather skewed market; limited insights from top-down valuations
As discussed in our June 7, 2020 report, the financials sector has dragged down the Indian
market’s performance over the past three months (see Exhibit 3) while other large-cap. stocks in
the consumer staples and discretionary, pharmaceuticals and telecom sectors are near or above
their pre-Covid-19 levels (see Exhibit 4). Thus, overall market valuations may have little relevance
given the skewed performance and valuations of sectors. Nonetheless, we show the valuation
of the Indian market on our usual metrics in Exhibit 5 and growth in net profits and breakdown
of net profits of the Nifty-50 Index by sectors in Exhibits 6-7.
Strategy Market
Opening economies, closing opportunities, Part 2. Near-term data on demand
recovery, capacity utilization and labor issues in consumption-related sectors may help
in getting a better handle on earnings. However, stock prices are already trading near
pre-Covid-19 levels despite downgrades to F2022E EPS. Near-term data may be more
relevant for financials stocks in terms of assessing the eventual level of NPLs and credit
costs as value exists in financials stocks assuming the situation ‘normalizes’ rapidly.
Exhibit 2: We have cut net profit of the Nifty-50 Index by 20% from pre-Covid-19 levels Pre-Covid-19 and current FY2022E volume, revenues, EBITDA, net profits and net worth estimates of the Nifty-50 stocks
(a) We use consensus numbers for Kotak Mahindra Bank.
P/E (X) EV/EBITDA (X) Performance
India Strategy
6 KOTAK INSTITUTIONAL EQUITIES RESEARCH
Exhibit 5: Nifty-50 Index is trading at fair valuations 1-year rolling forward P/E, P/B, ROE, EV/EBITDA and M3 growth rate adjusted valuations for Nifty-50 Index
Exhibit 6: We expect earnings of the Nifty-50 Index to decline 2.1% in FY2021 and grow 33% in FY2022 Valuation summary of Nifty-50 sectors (full-float basis), March fiscal year-ends, 2020E-22E (based on current constituents)
Exhibit 7: Banks, metals & mining and oil, gas & consumable fuels sectors to drive incremental profits of the Nifty-50 Index in FY2019-22E;
downside risks to earnings exist though Break-up of net profits of the Nifty-50 Index across sectors, March fiscal year-ends, 2015-22 (based on current constituents)
Exhibit 8: We recommend large-cap. stocks in automobiles & components, banks, consumer staples and telecommunication services KIE large-cap. model portfolio
Source: Kotak Institutional Equities estimates
Exhibit 9: Large value in many mid-cap. stocks KIE mid-cap. model portfolio
For Private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES’ RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.
4QFY20 EBITDA margin dented by a few one-offs
HMCL reported 4QFY20 EBITDA of Rs6.6 bn (down 38% yoy), which was 1% below our
estimates due to (1) higher-than-expected other expenses and (2) negative Rs1.8 bn impact
from a few one-offs. The company highlighted that 4QFY20 EBITDA got impacted due to (1)
Rs1.1 bn negative impact on account of higher discounts given to dealers (Rs10,000-Rs15,000
per vehicle) to clear off BS-IV inventories, (2) Rs0.37 bn impact from higher provision for fiscal
benefit of Neemrana plant (part of other operating income) and (3) the remaining Rs0.33 bn
impact related to write-off of BS-IV finished goods inventory. Revenues declined by 21% yoy led
by (1) 21% yoy volume decline due to subdued industry demand environment and (2) the
impact from a few one-offs mentioned above, which was partly offset by 6% yoy increase in
ASPs due to price hikes related to safety norms and higher mix of BS-VI vehicles in 4QFY20.
EBITDA margin came in at 10.6% (-300 bps yoy, -420 bps qoq), which was 40 bps below our
estimates. Adjusted for one-offs, the company would have reported EBITDA margin of 13.5%.
On per vehicle basis (adjusted for one-offs), the company’s gross profit per vehicle increased by
11% yoy to Rs15,275 and EBITDA per vehicle increased by 8% yoy to Rs6,481. Sequential
decline in gross margins can be attributed to the higher mix of BS-VI vehicles (50% in 4QFY20
versus nil in 3QFY20). Reported PAT was Rs6.2 bn (-15% yoy), 34% higher than our estimates
due to a lower tax rate.
Cost-saving program and RM tailwinds to support operating margins in FY2021E
Given gradual unlocking of the economy as well as gradual pick-up in capacity utilization (due
to multiple headwinds in terms of labor shortage and possibility of supply-chain disruptions), we
expect HMCL’s volumes to decline by 20% yoy in FY2021E. We expect HMCL’s volumes to
(1) decline by 80% yoy in 1QFY21 and 30% yoy in 2QFY21 and (2) grow by 4-5% yoy in
3QFY21 and 50% yoy in 4QFY21. However, we expect demand to recover in FY2022E with
21% yoy increase in volumes. We believe our volume assumptions are conservative given our
FY2022E volume forecast is still below FY2020 levels and we see an upside risk to our volume
assumptions if rural demand recovers swiftly. However, we expect operating margins to remain
firm led by (1) further savings from LEAP program – target to save 100 bps in FY2020 (50 bps
cost savings already achieved in FY2019), (2) softer RM prices and (3) control on overhead costs.
Total volumes 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Yoy chg (%)
Automobiles & Components Hero Motocorp
12 KOTAK INSTITUTIONAL EQUITIES RESEARCH
Exhibit 2: EBITDA per vehicle stood at Rs4,945 (-17% yoy) in 4QFY20 Hero Motocorp’s quarterly EBITDA per vehicle, March fiscal year-ends, 2016-20 (Rs per unit)
Source: Company, Kotak Institutional Equities
Exhibit 3: We cut our FY2021E EPS estimates by 12% on lower volume assumptions partly offset by increase in EBITDA margin assumption Earnings estimates revision, March fiscal year-ends, 2020-22E (Rs mn, units)
Source: Kotak Institutional Equities estimates
Exhibit 4: Hero’s market share in the scooter segment increased by 320 bps on yoy basis in 4QFY20 Market share across two-wheeler segments, March fiscal year-ends, 4QFY17-4QFY20 (%)
Exhibit 5: We expect Hero Motocorp’s volumes to grow at 3% CAGR over 2020-23E Hero MotoCorp volumes estimates, March fiscal year-ends, 2013-23E (mn units, %)
Exhibit 6: We expect Hero Motocorp’s EPS to grow at 7% CAGR over 2020-23E Hero MotoCorp profit model, balance sheet and cash flow model, March fiscal year-ends, 2013-23E (Rs mn)
For Private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES’ RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.
4QFY20 results boosted by strong growth in revenues and higher margins
Dhanuka delivered 18% yoy growth in revenues to Rs2.3 bn in 4QFY20 led by higher
realization and volumes amid spillover from a strong Rabi season. Gross margins increased by
~80 bps yoy and ~770 bps qoq to 42.8% benefiting from—(1) improvement in product mix
and (2) moderation in input costs. EBITDA increased 39% yoy to Rs458 mn, with margins
increasing by ~300 bps yoy to 20.1%, led by curtailment of distribution expenses and operating
leverage. Net income jumped 46% yoy to Rs390 mn (EPS of Rs8.2) led by reduction in effective
tax rate to 22.5%. In FY2020, EBITDA increased 19% to Rs1.74 bn driven by 11% growth in
revenues and lower operating costs; net income increased 26% to Rs1.42 bn (EPS of Rs29.7).
Optimistic outlook for FY2021. The management indicated that placements in 1QFY21 are
progressing at a good pace, growing at double-digits over previous year. Revenue is
expected to grow by healthy double-digits during FY2021 underpinned by (1) forecast of a
normal monsoon season, (2) benign reservoir levels and soil moisture content and (3) likely
increase in acreages. The company anticipates EBITDA margins to rise by ~100 bps in FY2021
due to (1) recent moderation in costs of key inputs amid resumption of supplies from China
and (2) cost-curtailment measures undertaken by the company.
New product launches. The company has launched two new products in 1QFY21—(1) a
pre-emergent weed herbicide for soybean and ground nuts and (2) a cotton herbicide; it is
planning to launch two new grape herbicides in the near term. The management indicated a
total revenue potential of around Rs5 bn from five new products launched during FY2020
and another two launched in 1QFY21.
Limited impact from pesticides ban. The company expects limited impact from the
potential ban of pesticides listed in the recent draft order, given availability of alternatives for
its key products. The company expects the ban to be limited to ~4-5 products with high
levels of toxicity out of 27 formulations proposed to be banned in the draft notification.
Raise FY2021-22 EPS estimates; retain SELL with a revised fair value of Rs535
We raise EPS estimates to Rs34.9 (+15%) in FY2021 and Rs38.2 (+14%) in FY2022 factoring in
(1) higher revenue growth, (2) modestly higher margins and (3) other minor changes. We retain
SELL with a revised fair value of Rs535 (Rs470 earlier) at 14X FY2022E EPS, as we find the risk-
reward balance unfavorable post the recent sharp rally in the stock amid near-term optimism.
Book value (Rs/share) 96 104 129 135 149 155 163 171
ROAE (%) 22.0 21.7 19.8 15.2 18.0 19.7 20.7 22.0
ROACE (%) 21.5 20.3 20.3 14.3 18.6 20.2 21.2 22.7
For Private Circulation Only. FOR IMPORTANT INFORMATION ABOUT KOTAK SECURITIES’ RATING SYSTEM AND OTHER DISCLOSURES, REFER TO THE END OF THIS MATERIAL.
Temporary staffing: decent performance in a challenging environment
Staffing segment had a decent 4Q performance, with core associate headcount increasing by
4.7% yoy to ~161k. TeamLease witnessed improvement in PAPM (per person average monthly
mark-up) in 4QFY20, which increased by 5% yoy primarily on account of higher contribution
from mid-tier accounts. EBITDA margin for the segment rebounded sequentially on account of
higher PAPM as well as cost cuts. Company expects e-commerce, logistics, FMCG, essential
retail to recover first post-covid, with manufacturing and BFSI to recover in 2HFY21.
HR services segment: remains under pressure
HR services segment reported another quarter of loss on account of provisioning against expected
shortfall in collections from corporates. This segment comprises the company’s training business
which provides services to corporates and government. Surprisingly, collections from government
have improved off late and the provisioning is against corporate receivables. Overall, compared
to EBITDA of Rs83 mn in FY2019, this segment swung to a sizeable loss of Rs88 mn in FY2020,
and accounted for the relatively flat overall EBITDA performance of the company.
Specialized staffing: should see decent momentum in FY2021 also
Specialized staffing business had a stable performance. Revenue growth of 34% yoy was aided
by contributions made by E-centric and IMSI, both of which provide staffing and related services
to IT sector and may see some tailwinds from the current demand for improved IT
infrastructure, BPM and related services. Further, TeamLease has been gaining share in staffing
services to captive IT development centers, which augurs well for its FY2021 pipeline.
Upgrade to ADD with a new FV of Rs1,875
Sharp stock price performance as well as our view that TeamLease can continue to enjoy
Section 80JJAA tax benefits longer than the earlier assumed time limit of FY2025 are the key
reasons for our upgrade. Several state-wide labor law relaxations also augur well. We revise
down our FY2021-22 EPS estimates by 35-40% as we incorporate a weak FY2020 as well as
covid impact on staffing and demand for other services. Upgrade to ADD with a revised FV of
Rs1,875.
TeamLease Services (TEAM) Commercial & Professional Services
Upgrade to ADD. We upgrade TeamLease to ADD from SELL following a sharp
correction in stock price and a more favorable outlook on Section 80JJAA tax benefit.
4QFY20 performance was weaker than expected due to Rs60 mn of provisions taken in
the HR services and IT staffing segments. Covid will certainly impact TeamLease’s
business and we thus revise down our FY2021/22 PAT estimates by 41/35%. Upgrade
to ADD with a revised SoTP-based FV of Rs1,875 (Rs2,300 earlier).
ADD
JUNE 11, 2020
RESULT, CHANGE IN RECO.
Sector view: Cautious
CMP (`): 1,726
Fair Value (`): 1,875
BSE-30: 34,247
Garima Mishra
Shubhangi Nigam
TeamLease Services
Stock data Forecasts/valuations 2020 2021E 2022E
52-week range (Rs) (high,low) EPS (Rs) 20.5 49.9 68.0
4QFY20 contained additional provisioning of Rs60-65 mn in the HR services and IT
segments. There is also a large unallocated cost element which contains some regular
provisioning; against this other income which contains certain reversals of earlier
provisioning is also high.
Exhibit 2: Yoy margin compression led primarily by the HR services segment Segmental revenue and margin snapshot of TeamLease, March fiscal year-ends (Rs mn)
BUY. We expect this stock to deliver more than 15% returns over the next 12 months.
ADD. We expect this stock to deliver 5-15% returns over the next 12 months.
REDUCE. We expect this stock to deliver -5-+5% returns over the next 12 months.
SELL. We expect this stock to deliver <-5% returns over the next 12 months.
Our Fair Value estimates are also on a 12-month horizon basis.
Our Ratings System does not take into account short-term volatility in stock prices related to movements in the market. Hence, a particular Rating may not
strictly be in accordance with the Rating System at all times.
Other definitions
Coverage view. The coverage view represents each analyst’s overall fundamental outlook on the Sector. The coverage view will consist of one of the following
designations: Attractive, Neutral, Cautious.
Other ratings/identifiers
NR = Not Rated. The investment rating and fair value, if any, have been suspended temporarily. Such suspension is in compliance with applicable regulation(s)
and/or Kotak Securities policies in circumstances when Kotak Securities or its affiliates is acting in an advisory capacity in a merger or strategic transaction
involving this company and in certain other circumstances.
CS = Coverage Suspended. Kotak Securities has suspended coverage of this company.
NC = Not Covered. Kotak Securities does not cover this company.
RS = Rating Suspended. Kotak Securities Research has suspended the investment rating and fair value, if any, for this stock, because there is not a sufficient
fundamental basis for determining an investment rating or fair value. The previous investment rating and fair value, if any, are no longer in effect for this stock
and should not be relied upon.
NA = Not Available or Not Applicable. The information is not available for display or is not applicable.
NM = Not Meaningful. The information is not meaningful and is therefore excluded.
Kotak Institutional Equities Research coverage universeDistribution of ratings/investment banking relationships
Source: Kotak Institutional Equities As of March 31, 2020
Percentage of companies covered by Kotak Institutional
Equities, within the specified category.
* The above categories are defined as follows: Buy = We
expect this stock to deliver more than 15% returns over the next
12 months; Add = We expect this stock to deliver 5-15% returns
over the next 12 months; Reduce = We expect this stock to
deliver -5-+5% returns over the next 12 months; Sell = We
expect this stock to deliver less than -5% returns over the next
12 months. Our target prices are also on a 12-month horizon
basis. These ratings are used illustratively to comply with
applicable regulations. As of 31/03/2020 Kotak Institutional
Equities Investment Research had investment ratings on 204
equity securities.
Percentage of companies within each category for which Kotak
Institutional Equities and or its affiliates has provided
investment banking services within the previous 12 months.47.1%
23.0%
12.7%
17.2%
3.9%2.0%
0.0% 1.5%
0%
10%
20%
30%
40%
50%
60%
70%
BUY ADD REDUCE SELL
Corporate Office Overseas Affiliates
Kotak Securities Ltd.
27 BKC, Plot No. C-27, “G Block”
Bandra Kurla Complex, Bandra (E)
Mumbai 400 051, India
Tel: +91-22-43360000
Kotak Mahindra (UK) Ltd
8th Floor, Portsoken House
155-157 Minories
London EC3N 1LS
Tel: +44-20-7977-6900
Kotak Mahindra Inc
369 Lexington Avenue
28th Floor, New York
NY 10017, USA
Tel:+1 212 600 8856
Copyright 2020 Kotak Institutional Equities (Kotak Securities Limited). All rights reserved. 1. Note that the research analysts contributing to this report may not be registered/qualified as research analysts with FINRA; and
2. Such research analysts may not be associated persons of Kotak Mahindra Inc and therefore, may not be subject to NASD Rule 2711 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account.
3. Any U.S. recipients of the research who wish to effect transactions in any security covered by the report should do so with or through Kotak Mahindra Inc and (ii) any transactions in the securities covered by the research by U.S. recipients must be effected only through Kotak Mahindra Inc at [email protected].
This report is distributed in Singapore by Kotak Mahindra (UK) Limited (Singapore Branch) to institutional investors, accredited investors or expert investors only as defined under the Securities and Futures Act. Recipients of this analysis / report are to contact Kotak Mahindra (UK) Limited (Singapore Branch) (16 Raffles Quay, #35-02/03, Hong Leong Building, Singapore 048581) in respect of any matters arising from, or in connection with, this analysis / report. Kotak Mahindra (UK) Limited (Singapore Branch) is regulated by the Monetary Authority of Singapore. Kotak Securities Limited and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We along with our affiliates are leading underwriter of securities and participants in virtually all securities trading markets in India. We and our affiliates have investment banking and other business relationships with a significant percentage of the companies covered by our Investment Research Department. Our research professionals provide important input into our investment banking and other business selection processes. Investors should assume that Kotak Securities Limited and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that the research professionals who were involved in preparing this material may participate in the solicitation of such business. Our research professionals are paid in part based on the profitability of Kotak Securities Limited, which include earnings from investment banking and other business. Kotak Securities Limited generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, Kotak Securities Limited generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest. Additionally, other important information regarding our relationships with the company or companies that are the subject of this material is provided herein. This material should not be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. We are not soliciting any action based on this material. It is for the general information of clients of Kotak Securities Limited. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, clients should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. Kotak Securities Limited does not provide tax advise to its clients, and all investors are strongly advised to consult with their tax advisers regarding any potential investment. Certain transactions -including those involving futures, options, and other derivatives as well as non-investment-grade securities - give rise to substantial risk and are not suitable for all investors. The material is based on information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied on as such. Opinions expressed are our current opinions as of the date appearing on this material only. We endeavor to update on a reasonable basis the information discussed in this material, but regulatory, compliance, or other reasons may prevent us from doing so. We and our affiliates, officers, directors, and employees, including persons involved in the preparation or issuance of this material, may from time to time have "long" or "short" positions in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. Kotak Securities Limited and its non US affiliates may, to the extent permissible under applicable laws, have acted on or used this research to the extent that it relates to non US issuers, prior to or immediately following its publication. Foreign currency denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the investment. In addition, investors in securities such as ADRs, the value of which are influenced by foreign currencies affectively assume currency risk. In addition options involve risks and are not suitable for all investors. Please ensure that you have read and understood the current derivatives risk disclosure document before entering into any derivative transactions. Kotak Securities Limited established in 1994, is a subsidiary of Kotak Mahindra Bank Limited. Kotak Securities is one of India's largest brokerage and distribution house. Kotak Securities Limited is a corporate trading and clearing member of Bombay Stock Exchange Limited (BSE), National Stock Exchange of India Limited (NSE), Metropolitan Stock Exchange of India Limited (MSE), National Commodity and Derivatives Exchange (NCDEX) and Multi Commodity Exchange(MCX). Our businesses include stock broking, services rendered in connection with distribution of primary market issues and financial products like mutual funds and fixed deposits, depository services and Portfolio Management. Kotak Securities Limited is also a depository participant with National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). Kotak Securities Limited is also registered with Insurance Regulatory and Development Authority as Corporate Agent for Kotak Mahindra Old Mutual Life Insurance Limited and is also a Mutual Fund Advisor registered with Association of Mutual Funds in India (AMFI). Kotak Securities Limited is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014. We hereby declare that our activities were neither suspended nor we have defaulted with any stock exchange authority with whom we are registered in last five years. However SEBI, Exchanges and Depositories have conducted the routine inspection and based on their observations have issued advise letters or levied minor penalty on KSL for certain operational deviations. We have not been debarred from doing business by any Stock Exchange / SEBI or any other authorities; nor has our certificate of registration been cancelled by SEBI at any point of time. We offer our research services to primarily institutional investors and their employees, directors, fund managers, advisors who are registered with us Details of Associates are available on website i.e. www.kotak.com Research Analyst has served as an officer, director or employee of subject company(ies): No We or our associates may have received compensation from the subject company(ies) in the past 12 months. We or our associates have managed or co-managed public offering of securities for the subject company(ies) in the past 12 months. YES. Visit our website for more details We or our associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company(ies) in the past 12 months. We or our associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company(ies) in the past 12 months. We or our associates may have received compensation or other benefits from the subject company(ies) or third party in connection with the research report. Our associates may have financial interest in the subject company(ies). Research Analyst or his/her relative's financial interest in the subject company(ies): No Kotak Securities Limited has financial interest in the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report: Hero Motocorp - YES Nature of Financial interest: Holding equity shares or derivatives of the subject company. Our associates may have actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report. Research Analyst or his/her relatives has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report: No Kotak Securities Limited has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report: No Subject company(ies) may have been client during twelve months preceding the date of distribution of the research report. A graph of daily closing prices of securities is available at https://www.moneycontrol.com/india/stockpricequote/ and http://economictimes.indiatimes.com/markets/stocks/stock-quotes. (Choose a company from the list on the browser and select the"three years" icon in the price chart).
Kotak Securities Limited. Registered Office: 27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400051. CIN: U99999MH1994PLC134051, Telephone No.: +22 43360000, Fax No.: +22 67132430. Website: www.kotak.com / www.kotaksecurities.com. Correspondence Address: Infinity IT Park, Bldg. No 21, Opp. Film City Road, A K Vaidya Marg, Malad (East), Mumbai 400097. Telephone No: 42856825. SEBI Registration No. INZ000200137(Member of NSE, BSE, MSE, MCX & NCDEX). Member Id: NSE-08081; BSE-673; MSE-1024; MCX-56285; NCDEX-1262. AMFI ARN 0164, PMS INP000000258 and Research Analyst INH000000586. NSDL/CDSL: IN-DP-NSDL-23-97. Compliance Officer Details: Mr. Manoj Agarwal. Call: 022 - 4285 8484, or Email: [email protected]. Investments in securities market are subject to market risks, read all the related documents carefully before investing. In case you require any clarification or have any concern, kindly write to us at below email ids: Level 1: For Trading related queries, contact our customer service at ‘[email protected]’ and for demat account related queries contact us at [email protected] or call us on: Toll free numbers 18002099191 / 1860 266 9191 Level 2: If you do not receive a satisfactory response at Level 1 within 3 working days, you may write to us at [email protected] or call us on 022-42858445 and if you feel you are still unheard, write to our customer service HOD at [email protected] or call us on 022-42858208. Level 3: If you still have not received a satisfactory response at Level 2 within 3 working days, you may contact our Compliance Officer (Name: Mr. Manoj Agarwal) at [email protected] or call on 91- (022) 4285 8484. Level 4 : If you have not received a satisfactory response at Level 3 within 7 working days, you may also approach Managing Director / CEO (Mr. Jaideep Hansraj) at [email protected] or call on 91-(022) 4285 8301. First Cut notes published on this site are for information purposes only. They represent early notations and responses by analysts to recent events. Data in the notes may not have been verified by us and investors should not act upon any data or views in these notes. Most First Cut notes, but not necessarily all, will be followed by final research reports on the subject. There could be variance between the First cut note and the final research note on any subject, in which case the contents of the final research note would prevail. We accept no liability for the contents of the First Cut Notes.